Lactococcus lactis as a vehicle for the heterologous expression of fungal ribotoxin variants with reduced IgE-binding affinity by Álvarez García, Elisa et al.
 1
Lactococcus lactis as a vehicle for the heterologous 
expression of fungal ribotoxin variants with reduced IgE-
binding affinity. 
 
Elisa Álvarez-Garcíaa, Jorge Alegre-Cebolladaa, Eva Bataneroa, Vicente 
Monederob, Gaspar Pérez-Martínezb, Rosa García-Fernándezc, Jose G. 
Gavilanesa, Álvaro Martínez del Pozoa,*. 
 
aDepartamento de Bioquímica y Biología Molecular I, Facultad de Ciencias 
Químicas, Universidad Complutense, 28040 Madrid, Spain. 
bLaboratorio de Bacterias Lácticas y Probióticos. IATA-CSIC, P.O. Box 73, 
46100 Burjassot, Valencia, Spain 
cDepartamento de Medicina y Cirugía Animal, Facultad de Veterinaria, 
Universidad Complutense, 28040 Madrid, Spain. 
 
Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; SRL, 
sarcin-ricin loop; GRAS, “Generally Regarded As Safe”; PCR, polymerase chain 
reaction; H&E, haematoxylin and eosin. 
*Corresponding author. Tel: +34 91 394 4259. Fax: 34 91 394 4159. 
E.mail address: alvaro@bbm1.ucm.es. 
 
 2
Abstract 
 
Fungal ribotoxins are a family of extracellular ribonucleases which inhibit 
protein biosynthesis by inactivating the ribosomes. This inactivation results in 
the induction of cell death by apoptosis. Ribotoxins show antitumoral properties 
based on their ability to cross the membrane of some transformed cells. 
Unfortunately, they also show an unspecific cytotoxicity which has greatly 
impaired their potential clinical uses. α-Sarcin, produced by Aspergillus 
giganteus, is the best characterized ribotoxin. Asp f 1, another ribotoxin 
produced by Aspergillus fumigatus, is indeed one of its major allergens. In this 
work, the Lactococcus lactis MG1363 strain has been engineered to produce 
and secrete not only wild-type Asp f 1 and α-sarcin but also three different 
mutants with reduced cytotoxicity and/or IgE-binding affinity. The proteins were 
secreted in native and active form when the extracellular medium employed 
was buffered at pH values around 8.0. Strains producing the wild-type natural α-
sarcin were proved to be innocuous when administered intragastrically to mice 
for a period of 14 days. Overall, the results presented are discussed in terms of 
its potential application as a vehicle of oral delivery of hypoallergenic variants as 
well as a starting point to approach the design of strategies to accomplish the 
safe delivery of these proteins as antitumoral agents. 
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1. Introduction 
 
Aspergillus species are responsible for several human lung pathologies, 
including different allergic inhalant diseases (Kurup et al., 2002), allergic 
bronchopulmonary aspergillosis (ABPA) being the most severe form among 
them. Aspergillus fumigatus is usually the mold involved in most of those 
diseases, ABPA included, because this fungus, with small spores, optimally 
grows at 37ºC, a temperature that is prohibitive for most of the other 
environmental ubiquitous fungi. Thus, it can colonize the respiratory tract of the 
host leading to the onset of pathological events (Banerjee and Kurup, 2003). 
Ribotoxins are a group of secreted fungal ribonucleases, best 
represented by α-sarcin (Lacadena et al., 2007), whose toxicity comes from 
their ability to reach the cytosol via endocytosis without establishing any 
receptor interaction (Olmo et al., 2001). They inhibit protein biosynthesis by 
inactivating the ribosomes (Schindler and Davies, 1977; Kao et al., 2001) which 
results in induction of cell death by apoptosis (Olmo et al., 2001). This ribosome 
inactivation is achieved by cleaving a unique phosphodiester bond at the so 
called sarcin-ricin loop (SRL) of the largest rRNA (Endo and Wool, 1982; Correll 
et al., 1999). Ribotoxins were discovered during a screening program of the 
Michigan Department of Health searching for antibiotics and antitumor agents 
(Olson et al., 1965). Unfortunately, further studies revealed an unspecific 
cytotoxicity of these proteins, which limited their potential clinical uses (Roga et 
al., 1971). 
All ribotoxins show a high degree of sequence identity with most of their 
differences appearing on exposed regions, such as their NH2-terminal β-hairpin 
(α-sarcin residues 1–26), a domain which can be considered as two 
consecutive minor β-sheets connected by a hinge region. The second of them 
(residues 7-22) juts out as a solvent-exposed protuberance and is one of the 
protein regions with highest conformational flexibility (Pérez-Cañadillas et al., 
2000, 2002). Deletion of this β-sheet results in a Δ(7–22) mutant that shows no 
significant conformational differences except for the deleted region (García-
Mayoral et al., 2004) but has lost its ability to specifically recognize the 
ribosome and is much less cytotoxic (García-Ortega et al., 2002). 
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Asp f 1, the ribotoxin produced by A. fumigatus, is also a major and one 
of its best-characterized allergens (Moser et al., 1992). There is a significant 
prevalence of Asp f 1-specific IgE antibodies in sera from patients sensitized to 
Aspergillus. Particularly in ABPA, the detection of these antibodies seems to be 
a promising approach for its otherwise difficult diagnosis (Kao et al., 2001; 
Greenberger, 2002; Banerjee and Kurup, 2003; García-Ortega et al., 2005). 
Asp f 1 differs from α-sarcin in only 19 (87% sequence identity) out of 150 
residues. Five of these differences are precisely located at the NH2-terminal β-
hairpin. Structural and immunogenic studies of Asp f 1, α-sarcin, and two 
variants where this β-hairpin had been deleted [Asp f 1 Δ(7–22) and α-sarcin 
Δ(7–22)] (García-Ortega et al., 2005) showed that the deleted portion is 
involved in at least one allergenic epitope (García-Mayoral et al., 2004; García-
Ortega et al., 2005). In spite of their decreased IgE reactivity, the prevalence of 
the two deleted proteins among the sera of patients remained essentially 
unaffected while they still retained most of the IgG epitopes (García-Ortega et 
al., 2005). It was then concluded that these ribotoxins’ variants might be 
suitable for use in immunomodulating therapies and diagnosis of Aspergillus 
hypersensitivity. 
 The digestive tract is inhabited by commensal flora, whose correct 
settlement has been shown to be very important for human health. In fact, some 
pathological states can be improved just by means of administration of certain 
live bacteria, the so-called probiotics (Hooper and Gordon, 2001; Schiffrin and 
Blum, 2001). In the last years, the setting-up of genetic engineering techniques 
has made possible the genetic modification of commensal bacteria in order to 
obtain “biodrugs”, i.e., strains of bacteria capable of in vivo producing drugs, 
antimicrobial agents, or vaccines (Hooper and Gordon, 2001; Blanquet et al., 
2001). One of the advantages of these “biodrugs” is the specific delivery of the 
therapeutic agent to their target. 
Lactococcus lactis is a non pathogenic, non invasive, no colonizing 
Gram-positive bacterium, mainly used to produce fermented foods. This lactic 
acid bacterium holds GRAS (“Generally Regarded As Safe”) status and hence 
is a suitable candidate to be used as one of those “biodrugs”. For example, it 
has been proven useful in producing IL-10 for the treatment of Inflammatory 
Bowel Disease in mice (Steidler et al., 2000). In this work, the extracellular 
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production by L. lactis of the above α-sarcin and Asp f 1 deletion variants is 
presented. Both wild-type proteins were also included in the study, as well as a 
properly folded, but catalytically inactive α-sarcin H137Q mutant, as a control 
(Lacadena et al., 1995; García-Ortega et al., 2002, 2005). The possibility of 
using this strategy as a potential immunomodulating therapeutic approach is 
discussed. 
 
2. Materials and Methods 
 
2.1. Materials 
All reagents were molecular biology grade. Restriction endonucleases 
and DNA modifying and synthesizing enzymes were purchased from Roche 
(Indianapolis, IN), New England Biolabs (Beverly, MA), or Promega (Madison, 
WI). Oligonucleotides were purchased from Sigma-Genosys (Cambridge, UK). 
Perkin-Elmer (Wellesley, MA) GeneAmpPCRSystem 2400 thermal cycler was 
used for the polymerase chain reaction (PCR) based amplifications. DNA 
sequencing was performed at the facility of the Universidad Complutense 
(Madrid, Spain). 
 
2.2. Media 
L. lactis strain MG1363 (Table 1) was routinely grown at 30ºC in M17 
(Difco) containing 0.5% (w/v) glucose (GM17) under static conditions, as 
described (Gil et al., 2001), adding erythromycin (5 µg/ml) when needed. In 
order to prepare electrocompetent cells, they were grown in GM17 medium but 
supplemented with 23.8 mg/ml L-Threonine, and 1 mM MgSO4 (GM17GT). 
Protein production was initially assayed in a medium (GM9) containing 0.042 M 
Na2HPO4, 0.02 M KH2PO4, 0.01 M NH4Cl, 8.5 mM NaCl, 2 mM MgSO4, 0.1 mM 
CaCl2, 5 g/l peptone, and 5 µg/ml erythromycin. Final production of the proteins 
was accomplished in 0.2 M potassium phosphate buffered GM9 (PM) adjusted 
at different pH values between 6.0 and 8.5. 
 
2.3. Cloning procedures 
Cloning procedures and DNA manipulations were carried out according 
to standard methods (Lacadena et al., 1994; Maassen, 1999; Schotte et al., 
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2000; Sambrook and Russell, 2001). Suitable deoxyoligonucleotides were used 
as primers for PCR amplification, using a series of plasmids constructed before 
as templates (Lacadena et al., 1994, 1995; García-Ortega et al., 2002, 2005), 
containing the cDNA corresponding to the five proteins studied: Asp f 1, α-
sarcin, Asp f 1 Δ(7–22), and α-sarcins Δ(7–22) and H137Q. These amplified 
DNA fragments were flanked by NgoMIV and BamHI restriction sites that were 
used to clone the proteins into the corresponding cloning sites of the plasmid 
pT1NX, in frame with the secretion signal leader of the lactococcal usp45 gene 
placed under the control of the constitutive promoter P1 (Steidler et al., 1995, 
2000). The vectors thus obtained (Table 1) were used to electroporate 
electrocompetent MG1363 L. lactis cells. 
 
2.4. L. lactis electroporation 
In order to prepare electrocompetent MG1363 L. lactis cells, the 
corresponding strain was grown overnight at 30ºC in 5 ml of GM17GT medium. 
Next day, this culture was diluted with fresh medium to a final volume of 25 ml 
and an OD600 of 0.1 and further incubated until reaching a value of 0.32. Cells 
were then harvested by centrifugation at 7500 g for 15 min. The cellular pellet 
was maintained in ice and washed twice with 2 ml of distilled water, once with 
1ml of 50 mM EDTA, and once with 1 ml of 0.3 M sucrose. Finally, washed cells 
were gently resuspended in 0.2 ml of 0.3 M sucrose and immediately used for 
electroporation. DNA ligation mixtures, or plasmids, used for electroporation 
were previously phenolized and ethanol precipitated in the presence of 50 μg/ml 
glycogen and redissolved in 10 μl of water. Electroporation was performed in a 
BioRad Gene Pulser apparatus at 2500 V, 200 ohm, and 25 μF, using 0.2 cm 
cuvettes and 2-3 μl (1 μg of DNA) of either the ligation mixtures or plasmids. 
Electroporated cells were quickly resuspended in 5 ml of GM17 containing 1% 
(w/v) sucrose and 1 mM MgSO4 and incubated for 2 hours at 30ºC. Selection of 
the proper colonies was then made for erythromycin (5 μg/ml) resistance on 
GM17 agar plates containing 1% (w/v) sucrose and 1 mM MgSO4, after 
incubation at 30ºC. 
 
2.5. Plasmids purification and analysis 
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Plasmids were purified essentially as described before (O’Sullivan and 
Klaenhammer, 1993; Maassen, 1999) by a method that combines enzymatic 
breakdown of the cell wall and purification of the plasmid by commercially 
available DNA-binding columns. With this purpose, the cells corresponding to 
10 ml of a 30ºC GM17 erythromycin (5 µg/ml) containing overnight culture were 
pelleted, resuspended in 200 μl of 10 mM HCl-Tris, pH 8.0, supplemented with 
20% (w/v) sucrose , 10 mM EDTA, 50 mM NaCl, and 15 mg/ml lysozyme, and 
further incubated for 15 min at 37ºC. This solution was then thoroughly but 
gently mixed with 200 μl of 0.2 M NaOH, containing 1% (w/v) SDS to induce the 
cell lysis. Cell lysates were subjected to fractionation using the standard 
procedure and reagents from GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich). 
Isolated plasmids were analyzed by electrophoretic restriction maps and DNA 
sequencing. 
 
2.6. Protein production 
Individual L. lactis colonies harboring each one of the five pT1NX-derived 
plasmids (Table 1) containing the different ribotoxins’ cDNA were cultured 
overnight at 30ºC in GM17 supplemented with 5 µg/ml erythromycin. Next day, 
500 µl of these saturated cultures were used to inoculate 50 ml of the same 
medium and further grown at 30ºC to an OD600 of 0.3. These cultures were 
centrifuged at 5000 g for 10 minutes at room temperature and the supernatant 
was discarded. The cellular pellet was gently resuspended in 50 ml of either 
GM9 or buffered PM media and incubated for 5 additional hours at 30ºC. These 
cultures were then processed as described in the following section. 
 
2.7. Protein analysis and detection 
L. lactis MG1363 grown for 5 hours in GM9 or buffered PM media were 
centrifuged at 15000 g for 15 minutes at room temperature and the 
supernatants were then 20-fold concentrated using Microcon YM-10 centrifugal 
filter devices, for detecting the proteins by Western blot, or 250-fold using 
Centiprep YM-10 centrifugal filter devices as well, for detecting them by staining 
with Coomassie blue or zymogram. These samples were analyzed on 0.1 % 
(w/v) SDS–PAGE performed in 15% (w/v) polyacrylamide gels (Laemmli, 1970). 
Gels containing the proteins thus fractionated were stained with Coomassie 
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brilliant blue R-250 or blotted onto Immobilon (Millipore) membranes by semidry 
blotting for 1 h at 0.48 mA/cm2. Immunodetection on these membranes was 
achieved as described (Lacadena et al., 1994; Villalba et al., 1994; García-
Ortega et al., 2005) employing rabbit polyclonal antibodies raised against wild-
type α-sarcin (Lacadena et al., 1994) or Asp f 1 (García-Ortega et al., 2005) and 
a secondary antibody horseradish peroxidase-labeled goat anti-rabbit IgG. The 
peroxidase reaction was developed using the ECL Western blotting reagent 
(Amersham Pharmacia Biotech) as described (Villalba et al., 1994; Barral et al., 
2004). The ribonucleolytic activity of the proteins was detected by using a 
zymogram assay against poly(A). This assay was performed at pH 7.0 in 15% 
(w/v) polyacrylamide gels containing 0.1% (w/v) SDS and 0.3 mg/mL of the 
homopolynucleotide. In these zymograms, proteins exhibiting ribonuclease 
activity appear as colorless bands after appropriate distaining (Lacadena et al., 
1999; Kao et al., 2001; García-Ortega et al., 2002). 
 
2.8. L. lactis oral administration to mice 
Female, 6 weeks old, BALB/c mice were obtained from Harlan Interfauna 
Ibérica S.A. (Barcelona, Spain). Animals were maintained at the Animal Care 
Services of the Faculty of Biology (UCM, Madrid, Spain), according to the local 
guidelines for animal care. The studies performed were approved by the Animal 
Experimentation Ethics Committee of the Complutense University. 
 Mice (n = 6) were inoculated daily via intragastric gaugage with 2 x 107 L. 
lactis cells suspended in 200 μl of bicarbonate solution during 14 consecutive 
days. Cells containing the α-sarcin producing pT1αsarcin plasmid or the pT1NX 
vector were used. Simultaneously a control group of 6 mice remained 
untreated. Two weeks after last inoculation the animals were sacrificed and gut 
histology was analyzed for injury. Intestine samples from all animals were fixed 
with formalin, routinely processed and paraffin-embedded. Sections of 3 μm 
were stained with haematoxylin and eosin (H&E) technique.  
These gut sections were examined under light microscopy by the mice 
pathologist blinded to the protocol design. 
For optimal α-sarcin production, the saturated cultures employed had 
been grown for 16 hours in GM17 containing 5 μg/ml erythromycin and then 
were diluted 25-fold in buffered PM medium and further grown for 3 more hours 
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at 30ºC. Then, the OD600 of these cultures was measured and they were diluted 
with the same medium in order to have the required 2 x 107 bacteria in 200 μl. 
 
3. Results 
 
3.1. α-Sarcin production 
α-Sarcin is the best characterized ribotoxin so far (Lacadena et al., 
2007). Thus, this protein was first used to optimize the extracellular ribotoxin’s 
production system in L. lactis. To this end, the α-sarcin cDNA was cloned into 
pT1NX plasmid fused to the usp45 lactococcal secretion signal. The initial 
production experiments, performed on GM9 medium, revealed the presence of 
an immunoreactive band in the extracellular culture medium of L. lactis carrying 
pT1αsarcin plasmid (Fig. 1). However, this band was of much higher 
electrophoretic mobility than wild-type α-sarcin. This suggested that L. lactis 
was able to secrete α-sarcin but also that proteolytic degradation of the 
recombinant protein was taking place. Considering that the final pH value of the 
cultures was around 4.5, in agreement with the results described by others 
employing similar systems (Israelsen et al., 1995; Gil et al., 2001), and that it 
has been reported the presence of acidic proteases within the extracellular 
medium of L. lactis, it seemed clear that the protein was being degraded. A very 
similar observation has been reported before for the heterologous expression of 
IL-10 using an almost identical system (Steidler et al., 2000). Therefore, the use 
of pH buffered media was considered. Consequently, cells were grown in PM at 
different pH values. As can be seen in Fig. 2, production of native wild-type α-
sarcin was maximal when pH values were around 8.0. Consequently, further 
production experiments of ribotoxins were performed in PM buffered at pH 8.0. 
 
3.2. Toxicity of the α-sarcin producing strain on mice 
Histological analysis of the three groups of mice studied (non-treated or 
treated with L. lactis carrying the cloning vector pT1NX or the expression 
plasmid pT1αsarcin) revealed the absence of significant differences among all 
them (Fig. 3), suggesting that oral administration of ribotoxins’ producing L. 
lactis strains had not deleterious effects on mice intestinal tracts. 
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3.3. Production of the other allergenic variants 
Once the extracellular production of wild-type α-sarcin was optimized, 
and its lack of toxicity was assessed, four other ribotoxins’ versions were also 
cloned and produced in L. lactis under identical conditions (Table 1). One of 
them was the wild-type major A. fumigatus allergen Asp f 1 (García-Ortega et 
al., 2005). Two other ones were the corresponding Δ(7-22) deleted variants of 
Asp f 1 and α-sarcin, two proteins with highly reduced IgE-reactivity and 
citotoxicity (García-Ortega et al., 2002, 2005; García-Mayoral et al., 2004). The 
fourth one (H137Q) was a mutant version of α-sarcin where only the 
catalytically essential His-137 has been mutated, being substituted by Gln 
(Lacadena et al., 1995). This mutation renders a fully inactive and non-cytotoxic 
protein that however retains the wild-type native conformation (Lacadena et al., 
1995, 1999). Protein production was scarcely detected in Coomassie Blue 
stained gels (data not shown), especially for the α-sarcin variants, but it was 
apparent in all cases when revealed by means of Western immunoblotting and 
ribonucleolytic activity against poly(A). Thus, immunoreactive bands 
corresponding to the expected electrophoretic mobilities were observed for all 
the five proteins studied (Fig. 4A). Indeed, except for the catalytically inactive 
H137Q mutant, all the other bands corresponded to ribonucleolytically active 
proteins and, as proven before (García-Ortega et al., 2002, 2005), this non-
specific activity was even higher for the deleted variants (Fig. 4B). 
 
4. Discussion 
 
There are growing evidences that regular consumption of foods 
containing probiotic bacteria may enhance the immune response and positively 
affect the indigenous microflora (Schiffrin and Blum, 2001). In addition, Gram-
positive bacteria not only do not have an outer cell membrane and do not 
produce endotoxins but rather their peptidoglycan layer appears to exhibit 
natural immuno-adjuvanticity (Pouwels et al., 1996). This explains why oral 
vaccination using GRAS Gram-positive bacteria is being developed as a 
promising approach to the onset of different pathologies, allergies included 
(Pouwels et al., 1996; Robinson et al., 1997; Maassen et al., 1999; Kirjavainen 
et al., 1999). 
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 L. lactis fed to animals and human volunteers passes rapidly through the 
gastrointestinal tract without colonization (Gruzza et al., 1994; Klijn et al., 1995). 
However, genetically modified versions of this microorganism are still effective 
in delivering antigens to the mucosal immune system and capable of inducing a 
local immune response (Robinson et al., 1997; Maassen et al., 1999; Adel-
Patient et al., 2005; Perez et al., 2005). This seems to happen because L. lactis 
lacks the ability to multiply in vivo but it can readily be sampled by dendritic 
cells. A process that seems to be involved in the development of efficient 
immune responses (Xin et al., 2003), including the selective induction of IgA 
(Macpherson and Uhr, 2004). In addition, antigens within Lactococci are 
protected against direct contact with gastric acid and proteolytic enzymes. For 
example, oral administration of recombinant L. lactis expressing bovine β-
lactoglobulin, a major cow’s milk allergen, was shown to induce a specific Th1 
response down-regulating a further Th2 one and thus preventing mice from 
sensitization (Adel-Patient et al., 2005). 
 Finally, only a few proteins are naturally secreted in L. lactis, but these 
bacteria can be engineered for secreting heterologous proteins to the 
extracellular medium, unlike most of Gram-negative bacteria in which the 
majority of secreted proteins are located in the periplasmic space (Nouaille et 
al., 2003). Altogether, all these facts make this organism optimally interesting 
for producing hypoallergenic proteins in order to use it as a vaccination vehicle. 
Following this idea, extracellular production of five different fungal 
ribotoxin variants was optimized in L. lactis MG1363. One of these variants was 
the wild-type ribotoxin Asp f 1, naturally produced by the human fungal 
pathogen A. fumigatus and one of its major allergens. Three other ones are 
natural and artificial variants of this protein displaying a diminished reactivity 
against human IgE from allergic patients (García-Ortega et al., 2005). Indeed, 
both deleted versions [Asp f 1 and α-sarcin Δ(7-22)] show a highly reduced 
cytoxicity due to the fact that they lack the ability to inactivate ribosomes 
specifically (García-Ortega et al., 2005). However, the four proteins secreted 
preserved their native conformation since all of them retained their 
ribonucleolytic activity against poly(A) (Fig. 4). The fifth protein produced was 
the α-sarcin mutant H137Q, a variant which is completely devoid of cytoxicity 
and ribonucleolytic activity (Fig. 4) (Lacadena et al., 1995, 1999; Olmo et al., 
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2001). Additionally, neither the bacterial strain alone nor the transformed 
producing natural wild-type α-sarcin did induce any deleterious effect on mice 
intestinal tract when intragastrically administered (Fig. 3), indicating that even 
the highly toxic wild-type ribotoxins could be safely delivered using L. lactis as a 
vehicle for oral administration. 
 It is well known how gastric pH values are rather low due the presence of 
high HCl concentrations. However, it has been also demonstrated how a 
significant fraction of L. lactis inocula can survive and be metabolically active in 
all the other compartments of the intestinal tract (Klijn et al., 1995, Corthier et 
al., 1998; Drouault et al., 1999) where pH values are much milder, approaching 
neutrality in many instances (Blanquet et al., 2001). Certainly, taking into 
account the results shown in Fig. 2, the possibility that the observed lack of 
toxicity might be due just to the instability of the protein produced cannot be 
ruled out. Nevertheless, the overall picture is far more complex. First, it is 
difficult to predict the in vivo suitability of these approaches since many different 
factors seem to affect cell viability and integrity within the digestive tract 
compartments (Drouault et al., 1999), including the presence of the many other 
microorganisms composing the intestinal flora. Second, native wild-type 
ribotoxins are rather acid pH and proteases resistant (Martínez del Pozo et al., 
1988). Third, as mentioned above, genetically engineered L. lactis using an 
identical plasmid to produce IL-10 were still therapeutically active in mice 
(Steidler et al., 2000) besides the fact that the in vitro production of this cytokine 
was also unstable at low pH values (Schotte et al., 2000). Finally, even if the 
proteins were being degraded they might be still useful as immunomodulating 
agents given that the resulting fragments are immunologically active (Fig. 2). 
Thus, in summary, it seems clear that the system described needs further 
evaluation in deeper detail at the in vivo level, especially in terms of direct 
detection of the activity and presence of the proteins within the mice 
gastrointestinal tract. However, at least within the idea of designing new 
immunomodulating therapeutical approaches, it seems safe to conclude that the 
system herein described combines the minimal features to be considered as 
optimally suitable for its potential application as a vehicle of oral delivery of 
hypoallergenic variants of Asp f 1. Finally, it has not escaped to our attention 
that given the antitumoural properties of ribotoxins (Olson et al., 1965; Olmo et 
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al., 2001), this system may also constitute a starting point to approach the 
design of strategies to accomplish the safe delivery of these proteins as 
antitumoral agents against different gastrointestinal tumors. 
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Table 1 
Strain and plasmids used in this study  
Strain or plasmid Genotype or relevant characteristics reference 
L. lactis MG1363 Plasmid-free derivative of NCDO712 Laboratory stock 
pT1NX L. lactis vector; erythromycin resistance; P1 
promoter and usp45 secretion signal 
Schotte et al., 2000 
pT1αsarcin pT1NX with cloned α-sarcin cDNA This work 
pT1αsarcinH137Q pT1NX with cloned α-sarcin H137Q variant This work 
pT1αsarcin7-22 pT1NX with cloned α-sarcin Δ(7-22) deletion variant This work 
pT1aspf pT1NX with cloned aspf1 cDNA This work 
pT1aspf7-22 pT1NX with cloned aspf1Δ(7-22) deletion variant This work 
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Fig. 1.   Electrophoretic separation on 0.1% SDS – 15% PAGE followed by 
Western immunoblot detection of α-sarcin in the extracellular media of overnight 
cultures of L. lactis MG1363 cells carrying the pT1αsarcin expression vector (1) 
or the pT1NX cloning vector (2). As a positive control, 50 ng of wild-type natural 
fungal α-sarcin were also loaded in lane 3. 
 
Fig. 2.   Electrophoretic separation on 0.1% SDS – 15% PAGE followed by 
Western immunoblot detection of α-sarcin in the extracellular media of buffered 
cultures of L. lactis [pT1αsarcin]. Numbers indicate the final pH values of the 
culture. Positive (50 ng of wild-type natural fungal α-sarcin, C+) and negative 
(no protein, C-) controls were also loaded. 
 
Fig. 3.   H&E stains of adult mouse small intestine sections. Samples from not 
treated mice (A) and from mice treated with L. lactis strains producing (B), or 
not (C), α-sarcin. Note the absence of pathological signs of inflammatory 
response in the muscularis, submucosa, and mucosa layers in all samples. It is 
also observed how the epithelium lining the intestine (surface epithelium) and 
the glands show no discrepancies among the three different groups of animals 
studied. Equivalent results were obtained with sections of different areas of the 
large intestine (data not shown). 
 
Fig 4.   A) Electrophoretic separation on 0.1% SDS – 15% PAGE followed by 
Western immunoblot detection and B) zymogram against poly(A) of 
concentrated culture supernatants of L. lactis carrying pT1αsarcinH137Q (lane 
2), pT1αsarcin (lane 3), pT1αsarcin7-22 (lane 4), pT1aspf (lane 5), pT1aspf7-22 
(lane 6). Lane 1 corresponds to L. lactis cells carrying the cloning vector 
pT1NX. Samples were not reduced before loading onto the gels. Immunoblot 
membrane corresponding to lanes 1 to 4 in part A) were stained using a rabbit 
polyclonal serum raised against wild-type α-sarcin, whereas an anti-Asp f 1 
serum was used for the area corresponding to lines 5 and 6. 




